Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Jun 15, 2016 $129.55 $129.55 $129.55 $129.55 1 671 513
Jun 14, 2016 $131.22 $131.22 $131.22 $131.22 1 904 893
Jun 13, 2016 $133.32 $133.32 $133.32 $133.32 1 649 483
Jun 10, 2016 $135.61 $135.61 $135.61 $135.61 1 980 192
Jun 09, 2016 $138.24 $138.24 $138.24 $138.24 2 371 229
Jun 08, 2016 $138.88 $138.88 $138.88 $138.88 2 951 987
Jun 07, 2016 $138.13 $138.13 $138.13 $138.13 5 632 726
Jun 06, 2016 $154.99 $154.99 $154.99 $154.99 755 366
Jun 03, 2016 $153.89 $153.89 $153.89 $153.89 1 480 549
Jun 02, 2016 $156.77 $156.77 $156.77 $156.77 1 550 507
Jun 01, 2016 $152.70 $152.70 $152.70 $152.70 975 029
May 31, 2016 $150.90 $150.90 $150.90 $150.90 1 115 948
May 27, 2016 $150.42 $150.42 $150.42 $150.42 1 094 201
May 26, 2016 $148.17 $148.17 $148.17 $148.17 908 707
May 25, 2016 $149.61 $149.61 $149.61 $149.61 1 392 093
May 24, 2016 $146.67 $146.67 $146.67 $146.67 1 165 233
May 23, 2016 $142.51 $142.51 $142.51 $142.51 981 837
May 20, 2016 $142.52 $142.52 $142.52 $142.52 975 544
May 19, 2016 $139.03 $139.03 $139.03 $139.03 1 290 936
May 18, 2016 $142.33 $142.33 $142.33 $142.33 1 242 385
May 17, 2016 $139.96 $139.96 $139.96 $139.96 1 544 418
May 16, 2016 $144.57 $144.57 $144.57 $144.57 1 293 032
May 13, 2016 $139.74 $139.74 $139.74 $139.74 1 134 581
May 12, 2016 $139.11 $139.11 $139.11 $139.11 1 141 351
May 11, 2016 $138.86 $138.86 $138.86 $138.86 1 121 997
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT